Measurement of factor XIII activity in plasma

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 7, 2012, Pages 1191-1202

  Katona, Éva ^a   Pénzes, Krisztina ^a   Molnár, Éva ^a   Muszbek, László ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Factor XIII; Factor XIII assays; Factor XIII deficiency

Indexed keywords

AMINE; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; FIBRIN; GLUTAMATE DEHYDROGENASE [NAD(P)]; GLUTAMINE;

AMINE INCORPORATION ASSAY; AMMONIA RELEASE ASSAY; BLOOD ANALYSIS; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD LEVEL; FIBRIN CLOT ANALYSIS; HUMAN; MEASUREMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; THROMBOSIS;

FACTOR XIII; FACTOR XIII DEFICIENCY; HUMANS; THROMBIN; THROMBOSIS;

EID: 84867757077     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0730     Document Type: Review

References (62)

1. Komaromi I, Bagoly Z, Muszbek L. Factor XIII: novel structural and functional aspects. J Thromb Haemost 2011;9:9-20.
2. Muszbek L, Bereczky Z, Bagoly Z, Komaromi I, Katona E. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011;91:931-72.
3. Iismaa SE, Holman S, Wouters MA, Lorand L, Graham RM, Husain A. Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases. Proc Natl Acad Sci USA 2003;100:12636-41.
4. Iismaa SE, Mearns BM, Lorand L, Graham RM. Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 2009;89:991-1023.
5. Muszbek L, Bereczky Z, Bagoly Z, Shemirani AH, Katona E. Factor XIII and atherothrombotic diseases. Semin Thromb Hemost 2010;36:18-33.
6. Biswas A, Ivaskevicius V, Seitz R, Thomas A, Oldenburg J. An update of the mutation profile of Factor 13 A and B genes. Blood Rev 2011;25:193-204.
7. Köhler HP, Ichinose A, Seitz R, Ariens RA, Muszbek L. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011;9:1404-6.
8. Muszbek L, Bagoly Z, Cairo A, Peyvandi F. Novel aspects of factor XIII deficiency. Curr Opin Hematol 2011;18:366-72.
9. Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII Deficiency. Semin Thromb Hemost 2009;35:426-38.
10. Bereczky Z, Balogh E, Katona E, Czuriga I, Edes I, Muszbek L. Elevated factor XIII level and the risk of myocardial infarction in women. Haematologica 2007;92:287-8.
11. Shemirani AH, Szomjak E, Csiki Z, Katona E, Bereczky Z, Muszbek L. Elevated factor XIII level and the risk of peripheral artery disease. Haematologica 2008;93:1430-2.
12. Bereczky Z, Muszbek L. Factor XIII and venous thromboembolism. Semin Thromb Hemost 2011;37:305-14.
13. Van Hylckama Vlieg A, Komanasin N, Ariens RA, Poort SR, Grant PJ, Bertina RM, et al. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol 2002;119:169-75.
14. Cushman M, O'Meara ES, Folsom AR, Heckbert SR. Coagulation factors IX through XIII and the risk of future venous thrombosis: the longitudinal investigation of thromboembolism etiology. Blood 2009;114:2878-83.
15. Laki K, Lorand L. On the solubility of fibrin clots. Science 1948;108:280.
16. Lorand L, Jacobsen A. Studies on the polymerization of fibrin; the role of the globulin: fibrin-stabilizing factor. J Biol Chem 1958;230:421-34.
17. Tyler HM. A comparative study of the solvents commonly used to detect fibrin stabilisation. Thromb Diath Haemorrh 1966;16:61-8.
18. Jennings I, Kitchen S, Woods TA, Preston FE. Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. J Thromb Haemost 2003;1:2603-8.
19. Jakobsen E, Godal HC. Simple, semiquantitative test for partial factor XIII (FSF) deficiency. Scand J Haematol 1974;12:366-8.
20. Francis JL. The detection and measurement of factor XIII activity: a review. Med Lab Sci 1980;37:137-47.
21. Chanarin I. Laboratory haematology: an account of laboratory techniques. Edinburgh; New York: Churchill Livingstone, 1989.
22. Shanbhag S, Shetty S, Kulkarni B, Ghosh K. An improved, semi quantitative clot based assay for factor XIII. Haemophilia 2011;17:718-20.
23. Loewy AG, Dunathan K, Kriel R, Wolfinger HL Jr., Fibrinase I. Purification of substrate and enzyme. J Biol Chem 1961;236:2625-33.
24. Bohn H. Isolation and characterization of the fibrin stabilizing factor from human thrombocytes. Thromb Diath Haemorrh 1970;23:455-68.
25. Sigg P. The monoiodoacetate (MIA) tolerance test, a new quantitative method for the fibrin stabilizing factor (factor 13) assay. Thromb Diath Haemorrh 1966;15:238-51.
26. Bohn H, Haupt H. A quantitative determination of factor 13 with anti-factor 13 serum. Thromb Diath Haemorrh 1968;19:309-15.
27. Retzinger GS, Cook BC, Smith RE, McGinnis MC. Quantitation of plasma factor XIIIa activity using fibrin-coated microscopic latex beads. Anal Biochem 1991;195:18-23.
28. Peyvandi F, Tagliabue L, Menegatti M, Karimi M, Komaromi I, Katona E, et al. Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat 2004;23:98.
29. Lorand L, Urayama T, De Kiewiet JW, Nossel HL. Diagnostic and genetic studies on fibrin-stabilizing factor with a new assay based on amine incorporation. J Clin Invest 1969;48:1054-64.
30. Muszbek L, Polgar J, Fesus L. Kinetic determination of blood coagulation Factor XIII in plasma. Clin Chem 1985;31:35-40.
31. Lee KN, Birckbichler PJ, Patterson MK Jr. Colorimetric assay of blood coagulation factor XIII in plasma. Clin Chem 1988;34:906-10.
32. Miraglia CC, Greenberg CS. Measurement of blood coagulation Factor XIIIa formation in plasma containing glycyl-L-prolyl-L-arginyl-L-proline. Anal Biochem 1985;144:165-71.
33. Fickenscher K, Aab A, Stuber W. A photometric assay for blood coagulation factor XIII. Thromb Haemost 1991;65:535-40.
34. Kárpáti L, Penke B, Katona E, Balogh I, Vamosi G, Muszbek L. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin Chem 2000;46:1946-55.
35. Kwon MH, Kong DH, Jung SH, Suh IB, Kim YM, Ha KS. Rapid determination of blood coagulation factor XIII activity using protein arrays for serodiagnosis of human plasma. Anal Chem 2011;83:2317-23.
36. Wilmer M, Rudin K, Kolde H, Poetzsch B, Lenz W, Moessmer G, et al. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency. Thromb Res 2001;102:81-91.
37. Song YC, Sheng D, Taubenfeld SM, Matsueda GR. A microtiter assay for factor XIII using fibrinogen and biotinylcadaverine as substrates. Anal Biochem 1994;223:88-92.
38. Dempfle CE, Harenberg J, Hochreuter K, Heene DL. Microtiter assay for measurement of factor XIII activity in plasma. J Lab Clin Med 1992;119:522-8.
39. Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 2000;96:988-95.
40. Balogh I, Szoke G, Karpati L, Wartiovaara U, Katona E, Komaromi I, et al. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 2000;96:2479-86.
41. Wartiovaara U, Mikkola H, Szoke G, Haramura G, Karpati L, Balogh I, et al. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost 2000;84:595-600.
42. Kohler HP, Ariens RA, Whitaker P, Grant PJ. A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 1998;80:704.
43. Raut S, Merton RE, Rigsby P, Muszbek L, Seitz R, Ariens RA, et al. A collaborative study to establish the 1st International Standard for factor XIII plasma. J Thromb Haemost 2007;5:1923-9.
44. Dvilansky A, Britten AF, Loewy AG. Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility. Br J Haematol 1970;18:399-410.
45. Lorand L, Campbell-Wilkes LK, Cooperstein L. A filter paper assay for transamidating enzymes using radioactive amine substrates. Anal Biochem 1972;50:623-31.
46. Schmer G. A solid-phase radioassay for factor-XIII activity (fibrin stabilizing factor) in human plasma. Br J Haematol 1973;24:735-42.
47. Nelson JC, Lerner RG Detection of factor XIIIa (active fibrinstabilizing factor) in normal plasma. Blood 1978;52:581-91.
48. Lorand L, Parameswaran KN, Velasco PT, Hsu LK, Siefring GE Jr. New colored and fluorescent amine substrates for activated fibrin stabilizing factor (Factor XIIIa) and for transglutaminase. Anal Biochem 1983;131:419-25.
49. Nishida Y, Ikematsu S, Fukutake K, Fujimaki MM Ploff E. A new rapid and simple assay for factor XIII ac dansylcadaverine incorporation and gel filtration. 1984;36:123-31.
50. Cooke RD, Holbrook JJ. Calcium and the assay plasma clotting factor XIII. Biochem J 1974;141:71
51. Wenzel E, Christ G. The formation of ammonia plasma following recalcification. Thromb Diath 1969;22:575-6.
52. Hellstern P, Schilz K, Von Blohn G, Wenzel E. Determination of factor XIII activity and of factor XIII inhibitors using an ammonium-sensitive electrode. Thromb Haemost 1983;50:563-6.
53. Mousli S, Wakid NW. Ammonia production during clot retraction and its use in assay of fibrinoligase. Clin Chem 1977;23:1739-43.
54. Lawrie AS, Green L, Mackie IJ, Liesner R, Machin SJ, Peyvandi F. Factor XIII - an under diagnosed deficiency - are we using the right assays? J Thromb Haemost 2010;8:2478-82.
55. Schmidt ES, Schmidt FW. Glutamate dehydrogenase. In: Bergmayer HU, editor. Methods of enzymatic analysis Volume III. Enzymes 1: Oxidoreductases, transferases. Weinheim: Verlag Chemie GmbH, 1983:216-27.
56. Recommendations of the German Society for Clinical Chemistry: standardisation of methods for the estimation of enzyme activity in biological fluids. J Clin Chem Clin Biochem 1970;8:659-60.
57. Da Fonseca-Wollheim F. Deamidation of glutamine by increased plasma gamma-glutamyltransferase is a source of rapid ammonia formation in blood and plasma specimens. Clin Chem 1990;36:1479-82.
58. Ajzner E, Muszbek L. Kinetic spectrophotometric factor XIII activity assays: the subtraction of plasma blank is not omissible [corrected]. J Thromb Haemost 2004;2:2075-7.
59. Meijer P. Clinically needed sensitivity for very low levels of Factor XIII: not yet proven for a new functional assay. Clin Chem Lab Med 2011; DOI:10.1515/CCLM.2011.649.
60. Kappel A, Stephan S, Christ G, Pechmann L, Duwe C, Fischer B, et al. Quantification of coagulation factor XIII activity by a thio-NADH based assay using factor XIII immuno-depleted plasma as a diluent for calibration. Clin Chem Lab Med 2010;48:1739-43.
61. Parameswaran KN, Cheng XF, Chen EC, Velasco PT, Wilson JH, Lorand L. Hydrolysis of gamma: epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J Biol Chem 1997;272:10311-7.
62. Oertel K, Hunfeld A, Specker E, Reiff C, Seitz R, Pasternack R, et al. A highly sensitive fl uorometric assay for determination of human coagulation factor XIII in plasma. Anal Biochem 2007;367:152-8.